Swedencare Zukünftiges Wachstum

Future Kriterienprüfungen 4/6

Swedencare wird ein jährliches Gewinn- und Umsatzwachstum von 50.2% bzw. 11.5% prognostiziert. Der Gewinn pro Aktie wird voraussichtlich wachsen um 50.2% pro Jahr. Die Eigenkapitalrendite wird in 3 Jahren voraussichtlich 4.6% betragen.

Wichtige Informationen

50.2%

Wachstumsrate der Gewinne

50.2%

EPS-Wachstumsrate

Pharmaceuticals Gewinnwachstum	54.2%
Wachstumsrate der Einnahmen	11.5%
Zukünftige Eigenkapitalrendite	4.6%
Analystenabdeckung	Low
Zuletzt aktualisiert	29 Apr 2024

Jüngste Aktualisierungen zum künftigen Wachstum

Recent updates

Analysts Just Published A Bright New Outlook For Swedencare AB (publ)'s (STO:SECARE)

Feb 16

Do Swedencare's (STO:SECARE) Earnings Warrant Your Attention?

Dec 28

A Look At The Fair Value Of Swedencare AB (publ) (STO:SECARE)

Dec 06

Swedencare (STO:SECARE) Has A Rock Solid Balance Sheet

Oct 24

With EPS Growth And More, Swedencare (STO:SECARE) Is Interesting

Sep 12

Calculating The Fair Value Of Swedencare AB (publ) (STO:SECARE)

Aug 19

Broker Revenue Forecasts For Swedencare AB (publ) (STO:SECARE) Are Surging Higher

Jul 28

Industry Analysts Just Made A Substantial Upgrade To Their Swedencare AB (publ) (STO:SECARE) Revenue Forecasts

Jul 01

Swedencare (STO:SECARE) Has A Rock Solid Balance Sheet

Jun 29

A Look At The Fair Value Of Swedencare AB (publ) (STO:SECARE)

May 06

Here's Why I Think Swedencare (STO:SECARE) Is An Interesting Stock

Apr 02

Could The Swedencare AB (publ) (STO:SECARE) Ownership Structure Tell Us Something Useful?

Mar 12

Gewinn- und Umsatzwachstumsprognosen

OM:SECARE - Zukünftige Analystenschätzungen und Finanzdaten der Vergangenheit (SEK Millions)
Datum	Umsatz	Gewinne	Freier Cashflow	Bargeld aus operativen Tätigkeiten	Durchschn. Anz. Analysten
12/31/2026	3,375	465	758	N/A	1
12/31/2025	3,000	343	650	N/A	2
12/31/2024	2,659	228	571	N/A	1
3/31/2024	2,414	72	381	415	N/A
12/31/2023	2,338	59	408	444	N/A
9/30/2023	2,199	87	410	444	N/A
6/30/2023	2,076	53	332	376	N/A
3/31/2023	1,987	97	257	314	N/A
12/31/2022	1,843	95	193	260	N/A
9/30/2022	1,600	98	96	170	N/A
6/30/2022	1,335	105	69	135	N/A
3/31/2022	1,019	60	114	161	N/A
12/31/2021	773	55	98	126	N/A
9/30/2021	618	40	90	106	N/A
6/30/2021	465	44	74	79	N/A
3/31/2021	337	34	45	48	N/A
12/31/2020	240	33	36	37	N/A
9/30/2020	174	34	26	29	N/A
6/30/2020	136	28	28	31	N/A
3/31/2020	134	30	20	24	N/A
12/31/2019	127	30	28	33	N/A
9/30/2019	121	30	27	32	N/A
6/30/2019	113	28	23	30	N/A
3/31/2019	108	27	21	28	N/A
12/31/2018	99	23	13	22	N/A
9/30/2018	94	23	16	21	N/A
6/30/2018	92	20	12	15	N/A
3/31/2018	85	17	10	14	N/A
12/31/2017	86	17	N/A	13	N/A
9/30/2017	78	12	N/A	4	N/A
6/30/2017	70	11	N/A	4	N/A
3/31/2017	63	12	N/A	4	N/A
12/31/2016	54	10	N/A	2	N/A
9/30/2016	43	9	N/A	8	N/A
6/30/2016	37	8	N/A	9	N/A
3/31/2016	34	8	N/A	5	N/A
12/31/2015	27	7	N/A	4	N/A
12/31/2014	24	4	N/A	4	N/A
12/31/2013	18	0	N/A	N/A	N/A

Analystenprognosen zum zukünftigen Wachstum

Einkommen vs. Sparrate: SECAREDas prognostizierte Gewinnwachstum (50.2% pro Jahr) liegt über der Sparquote (1%).

Ertrag vs. Markt: SECAREDie Erträge des Unternehmens (50.2% pro Jahr) werden voraussichtlich schneller wachsen als der Markt Swedish (14.1% pro Jahr).

Hohe Wachstumserträge: SECAREEs wird erwartet, dass die Erträge des Unternehmens in den nächsten 3 Jahren erheblich steigen werden.

Einnahmen vs. Markt: SECAREDie Einnahmen des Unternehmens (11.5% pro Jahr) werden voraussichtlich schneller wachsen als der Markt Swedish (1.9% pro Jahr).

Hohe Wachstumseinnahmen: SECAREDie Einnahmen des Unternehmens (11.5% pro Jahr) werden voraussichtlich langsamer wachsen als 20% pro Jahr.

Wachstumsprognosen für den Gewinn je Aktie

Künftige Eigenkapitalrendite

Künftige Eigenkapitalrendite: SECAREDie Eigenkapitalrendite des Unternehmens wird in 3 Jahren voraussichtlich niedrig sein (4.6%).

Swedencare Zukünftiges Wachstum

Future Kriterienprüfungen 4/6

Wichtige Informationen

Jüngste Aktualisierungen zum künftigen Wachstum

Price target increased by 8.7% to kr50.00

Price target decreased by 7.1% to kr46.00

Price target increased by 10% to kr49.50

Consensus EPS estimates fall by 31%, revenue upgraded

Price target decreased by 12% to kr42.00

Consensus EPS estimates fall by 27%

Recent updates

Swedencare AB (publ) to Report Q4, 2024 Results on Feb 13, 2025

Upcoming dividend of kr0.23 per share

Full year 2023 earnings: Revenues exceed analysts expectations while EPS lags behind

Full year 2023 earnings: Revenues exceed analysts expectations while EPS lags behind

Swedencare AB (Publ) Announces Nomination Committee Appointments

Price target increased by 8.7% to kr50.00

Third quarter 2023 earnings: EPS and revenues exceed analyst expectations

Swedencare AB (publ), Annual General Meeting, Apr 25, 2024

New minor risk - Share price stability

Price target decreased by 7.1% to kr46.00

Price target increased by 10% to kr49.50

Consensus EPS estimates fall by 31%, revenue upgraded

New minor risk - Profit margin trend

Second quarter 2023 earnings released: EPS: kr0.10 (vs kr0.49 in 2Q 2022)

Investor sentiment improves as stock rises 15%

Chief Executive Officer recently bought kr472k worth of stock

Symrise AG (XTRA:SY1) announces a mandatory public offer to acquire remaining 70% stake in Swedencare AB (publ) (OM:SECARE) for SEK 4.2 billion

Symrise AG (XTRA:SY1) announces a mandatory public offer to acquire remaining 70% stake in Swedencare AB (publ) (OM:SECARE) for SEK 4.2 billion

Investor sentiment improves as stock rises 15%

Less than half of directors are independent

Price target decreased by 12% to kr42.00

First quarter 2023 earnings: EPS misses analyst expectations

Does Swedencare (STO:SECARE) Deserve A Spot On Your Watchlist?

Investor sentiment improves as stock rises 22%

Upcoming dividend of kr0.22 per share at 0.8% yield

Chief Executive Officer recently bought kr241k worth of stock

Chief Executive Officer recently bought kr241k worth of stock

Consensus EPS estimates fall by 27%

Full year 2022 earnings: EPS and revenues miss analyst expectations

Price target decreased by 14% to kr47.25

Swedencare AB (publ) to Report Fiscal Year 2022 Final Results on Apr 06, 2023

Swedencare AB (publ) to Report First Half, 2023 Results on Jul 27, 2023

Swedencare AB (publ) to Report Fiscal Year 2022 Results on Feb 16, 2023

Investor sentiment improved over the past week

Chief Executive Officer recently bought kr315k worth of stock

Chief Executive Officer recently bought kr328k worth of stock

Swedencare (STO:SECARE) Seems To Use Debt Quite Sensibly

Swedencare AB (publ), Annual General Meeting, Apr 28, 2023

Investor sentiment deteriorated over the past week

Here's Why We Think Swedencare (STO:SECARE) Might Deserve Your Attention Today

Price target decreased to kr75.00

Investor sentiment improved over the past week

Investor sentiment deteriorated over the past week

Investor sentiment deteriorated over the past week

Investor sentiment deteriorated over the past week

With EPS Growth And More, Swedencare (STO:SECARE) Makes An Interesting Case

Consensus forecasts updated

Price target decreased to kr120

Second quarter 2022 earnings released: EPS: kr0.49 (vs kr0.31 in 2Q 2021)

Swedencare (STO:SECARE) Has A Pretty Healthy Balance Sheet

High number of new directors

Chief Executive Officer recently bought kr162k worth of stock

Consensus forecasts updated

Price target decreased to kr165

Less than half of directors are independent

Upcoming dividend of kr0.20 per share

Should You Be Adding Swedencare (STO:SECARE) To Your Watchlist Today?

Swedencare AB (publ) Proposes Dividend, Payable on 5 May 2022

Price target decreased to kr165

Swedencare AB (Publ) Proposes Dividend for 2021

Analysts Just Published A Bright New Outlook For Swedencare AB (publ)'s (STO:SECARE)

Now 23% undervalued after recent price drop

Swedencare AB (publ) (OM:SECARE) agreed to acquire The Garmon Corporation for approximately $470 million.

Do Swedencare's (STO:SECARE) Earnings Warrant Your Attention?

A Look At The Fair Value Of Swedencare AB (publ) (STO:SECARE)

Third quarter 2021 earnings released

Swedencare (STO:SECARE) Has A Rock Solid Balance Sheet

With EPS Growth And More, Swedencare (STO:SECARE) Is Interesting

Calculating The Fair Value Of Swedencare AB (publ) (STO:SECARE)